Sevelamer could be worth it in hyperphosphataemia

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.552, 2008-01, pp. : 3-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sevelamer could be worth it in hyperphosphataemia

Inpharma, Vol. 1, Iss. 1636, 2008-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Sevelamer Hydrochloride: A Review of its Use for Hyperphosphataemia in Patients with End-Stage Renal Disease on Haemodialysis

By Goldsmith David R. Scott Lesley J. Cvetković Risto S. Plosker Greg L.

Drugs, Vol. 68, Iss. 1, 2008-01 ,pp. : 85-104

Adis International

Access to resources Recommend Favorite

ESRD with hyperphosphataemia: an economic burden

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 505, 2006-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Compounds in development to combat hyperphosphataemia

By Hergesell O Ritz E

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 12, 2001-12 ,pp. : 2185-2190

Informa Healthcare

Access to resources Recommend Favorite

PEG IFN- -2b + ribavirin: 12 weeks' worth could do the trick in HCV

Inpharma, Vol. 1, Iss. 1494, 2005-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite